{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:14:39Z","timestamp":1778649279951,"version":"3.51.4"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012363","name":"Royal Embassy of Saudi Arabia Cultural Bureau in London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000691","name":"Academy of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/18\/79\/34106"],"award-info":[{"award-number":["PG\/18\/79\/34106"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["NIF\/R5A\/0017"],"award-info":[{"award-number":["NIF\/R5A\/0017"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"publisher","award":["19\/0006045"],"award-info":[{"award-number":["19\/0006045"]}],"id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ejphar.2026.178725","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T16:04:21Z","timestamp":1772899461000},"page":"178725","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Colchicine acutely reduces liver-secreted inflammatory and metabolic proteins in blood"],"prefix":"10.1016","volume":"1020","author":[{"given":"Magdalena","family":"Sovakova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iain R.","family":"Phair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika J.","family":"Gutierrez-Lara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5935-5453","authenticated-orcid":false,"given":"Raid B.","family":"Nisr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire S.","family":"Whyte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noor","family":"Alqurashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Yap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"McSorley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Lamont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7452-0813","authenticated-orcid":false,"given":"Nicola J.","family":"Mutch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4869-178X","authenticated-orcid":false,"given":"Alison D.","family":"McNeilly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9121-1350","authenticated-orcid":false,"given":"Graham","family":"Rena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.178725_bib1","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/S0022-2275(20)39135-5","article-title":"Expression of a novel human apolipoprotein (apoC-IV) causes hypertriglyceridemia in transgenic mice","volume":"37","author":"Allan","year":"1996","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejphar.2026.178725_bib2","doi-asserted-by":"crossref","first-page":"e1314","DOI":"10.1542\/peds.2013-0195","article-title":"Evaluation for bleeding disorders in suspected child abuse","volume":"131","author":"Anderst","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejphar.2026.178725_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/cells10102667","article-title":"Neutrophil extracellular Traps-DNase balance and autoimmunity","volume":"10","author":"Angeletti","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2026.178725_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2022.101725","article-title":"DIA label-free proteomic analysis of murine bone-marrow-derived macrophages","volume":"3","author":"Baker","year":"2022","journal-title":"STAR Protoc."},{"key":"10.1016\/j.ejphar.2026.178725_bib5","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2016.0221","article-title":"The mystery behind membrane insertion: a review of the complement membrane attack complex","volume":"372","author":"Bayly-Jones","year":"2017","journal-title":"Phil. Trans. Biol. Sci."},{"key":"10.1016\/j.ejphar.2026.178725_bib6","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1161\/01.ATV.19.10.2348","article-title":"Complement and atherogenesis","volume":"19","author":"Bhakdi","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2026.178725_bib7","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2353\/ajpath.2007.060406","article-title":"Complement C1q reduces early atherosclerosis in low-density lipoprotein receptor-deficient mice","volume":"170","author":"Bhatia","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2026.178725_bib8","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/ATVBAHA.124.319851","article-title":"Colchicine's role in cardiovascular disease management","volume":"44","author":"Buckley","year":"2024","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2026.178725_bib9","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1161\/01.CIR.0000019584.04929.83","article-title":"Influence of C3 deficiency on atherosclerosis","volume":"105","author":"Buono","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2026.178725_bib10","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1111\/j.1755-5922.2010.00171.x","article-title":"Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions","volume":"28","author":"Cesari","year":"2010","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.ejphar.2026.178725_bib11","article-title":"Carboxylesterase 2 proteins are efficient diglyceride and monoglyceride lipases possibly implicated in metabolic disease","volume":"62","author":"Chalhoub","year":"2021","journal-title":"JLR (J. Lipid Res.)"},{"key":"10.1016\/j.ejphar.2026.178725_bib12","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1161\/01.ATV.20.8.1852","article-title":"ApoE in atherosclerosis : a protein with multiple hats","volume":"20","author":"Curtiss","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2026.178725_bib14","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/ATVBAHA.124.318374","article-title":"Angiotensinogen as a therapeutic target for cardiovascular and metabolic diseases","volume":"44","author":"Daugherty","year":"2024","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2026.178725_bib15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/CIRCULATIONAHA.121.056171","article-title":"Colchicine in cardiovascular disease: in-depth review","volume":"145","author":"Deftereos","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2026.178725_bib16","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1038\/s41366-020-0598-3","article-title":"Colchicine's effects on metabolic and inflammatory molecules in adults with obesity and metabolic syndrome: results from a pilot randomized controlled trial","volume":"44","author":"Demidowich","year":"2020","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.ejphar.2026.178725_bib17","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.jacl.2019.10.011","article-title":"Colchicine's effects on lipoprotein particle concentrations in adults with metabolic syndrome: a secondary analysis of a randomized controlled trial","volume":"13","author":"Demidowich","year":"2019","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.ejphar.2026.178725_bib18","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1612790","article-title":"Genetic and pharmacologic inactivation of ANGPTL3 and cardiovascular disease","volume":"377","author":"Dewey","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2026.178725_bib19","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1161\/ATVBAHA.120.316389","article-title":"Hypercholesterolemia impairs clearance of neutrophil extracellular traps and promotes inflammation and atherosclerotic plaque progression","volume":"41","author":"Dhawan","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2026.178725_bib20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.molimm.2014.05.013","article-title":"Multiple roles of complement MASP-1 at the interface of innate immune response and coagulation","volume":"61","author":"Dob\u00f3","year":"2014","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ejphar.2026.178725_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237665","article-title":"Short-term effect of low-dose colchicine on inflammatory biomarkers, lipids, blood count and renal function in chronic coronary artery disease and elevated high-sensitivity C-reactive protein","volume":"15","author":"Fiolet","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.178725_bib22","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1182\/blood-2015-02-355974","article-title":"Activated protein C: biased for translation","volume":"125","author":"Griffin","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2026.178725_bib23","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1007\/s00204-022-03353-8","article-title":"Colchicine overdose impairs the capacity of Kupffer cells to clear foreign particles and endotoxins","volume":"96","author":"Hassan","year":"2022","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ejphar.2026.178725_bib24","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1161\/CIRCULATIONAHA.110.973222","article-title":"Immunotherapy with tolerogenic apolipoprotein B-100-loaded dendritic cells attenuates atherosclerosis in hypercholesterolemic mice","volume":"123","author":"Hermansson","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2026.178725_bib25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1476-511X-13-67","article-title":"Synergistic effects of colchicine combined with atorvastatin in rats with hyperlipidemia","volume":"13","author":"Huang","year":"2014","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.ejphar.2026.178725_bib26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/ATVBAHA.122.318062","article-title":"Apolipoprotein A1 protects against necrotic core development in atherosclerotic plaques: PDZK1-dependent high-density lipoprotein suppression of necroptosis in macrophages","volume":"43","author":"Kluck","year":"2023","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2026.178725_bib27","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.semarthrit.2015.06.013","article-title":"Colchicine\u2014update on mechanisms of action and therapeutic uses","volume":"45","author":"Leung","year":"2015","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2026.178725_bib28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/rth2.12175","article-title":"Hereditary angioedema: linking complement regulation to the coagulation system","volume":"3","author":"Levi","year":"2019","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.ejphar.2026.178725_bib29","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41598-020-79948-x","article-title":"Role of PAI-1 in hepatic steatosis and dyslipidemia","volume":"11","author":"Levine","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.178725_bib30","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.molimm.2009.10.035","article-title":"The membrane attack complex of complement drives the progression of atherosclerosis in apolipoprotein E knockout mice","volume":"47","author":"Lewis","year":"2010","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ejphar.2026.178725_bib31","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1016\/j.molimm.2007.06.006","article-title":"The relative importance of local and systemic complement production in ischaemia, transplantation and other pathologies","volume":"44","author":"Li","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ejphar.2026.178725_bib32","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1021\/acs.jproteome.4c00783","article-title":"Data-independent acquisition-based quantitative proteomics for pairwise comparison of serum and plasma","volume":"24","author":"Li","year":"2025","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.ejphar.2026.178725_bib33","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.lfs.2013.07.002","article-title":"Anti-cancer mechanisms of clinically acceptable colchicine concentrations on hepatocellular carcinoma","volume":"93","author":"Lin","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2026.178725_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00592","article-title":"C1 complex: an adaptable proteolytic module for complement and non-complement functions","volume":"8","author":"Lu","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2026.178725_bib35","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1096\/fj.10-174284","article-title":"Complement C5a inhibition reduces atherosclerosis in ApoE\u2013\/\u2013 mice","volume":"25","author":"Manthey","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2026.178725_bib36","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002128","article-title":"Colchicine acutely suppresses local cardiac production of inflammatory cytokines in patients with an acute coronary syndrome","volume":"4","author":"Mart\u00ednez","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ejphar.2026.178725_bib37","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/j.jacc.2020.02.058","article-title":"Complement C5 protein as a marker of subclinical atherosclerosis","volume":"75","author":"Mart\u00ednez-L\u00f3pez","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2026.178725_bib38","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1161\/CIRCULATIONAHA.108.830661","article-title":"Macrophage-specific expression of mannose-binding lectin controls atherosclerosis in low-density lipoprotein receptor-deficient mice","volume":"119","author":"Matthijsen","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2026.178725_bib39","article-title":"Colchicine for acute gout","author":"Mckenzie","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejphar.2026.178725_bib40","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.clinbiochem.2006.02.016","article-title":"Classical pathway complement activity in familial mediterranean fever","volume":"39","author":"Mkrtchyan","year":"2006","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ejphar.2026.178725_bib41","series-title":"Janeway's Immunobiology","author":"Murphy","year":"2017"},{"key":"10.1016\/j.ejphar.2026.178725_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0021-9150(87)90002-5","article-title":"Immunohistochemical localization of C5b-9, S-protein, C3d and apolipoprotein B in human arterial tissues with atherosclerosis","volume":"65","author":"Niculescu","year":"1987","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejphar.2026.178725_bib43","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.amjcard.2006.10.039","article-title":"Effect of colchicine (0.5 mg twice daily) on high-sensitivity C-reactive protein independent of aspirin and atorvastatin in patients with stable coronary artery disease","volume":"99","author":"Nidorf","year":"2007","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2026.178725_bib44","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2026.178725_bib45","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.molimm.2013.01.009","article-title":"The control of the complement lectin pathway activation revisited: both C1-inhibitor and antithrombin are likely physiological inhibitors, while \u03b12-macroglobulin is not","volume":"54","author":"Par\u00e9j","year":"2013","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ejphar.2026.178725_bib46","article-title":"AMPK integrates metabolite and kinase-based immunometabolic control in macrophages","author":"Phair","year":"2022","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.ejphar.2026.178725_bib47","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.molimm.2003.10.013","article-title":"Differential substrate and inhibitor profiles for human MASP-1 and MASP-2","volume":"40","author":"Presanis","year":"2004","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ejphar.2026.178725_bib48","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/imr.12500","article-title":"Complement component C3 - the \"Swiss Army Knife\" of innate immunity and host defense","volume":"274","author":"Ricklin","year":"2016","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ejphar.2026.178725_bib49","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCRESAHA.115.306656","article-title":"From C-Reactive protein to Interleukin-6 to Interleukin-1: moving upstream to identify novel targets for atheroprotection","volume":"118","author":"Ridker","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2026.178725_bib50","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2026.178725_bib51","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.amjmed.2021.07.025","article-title":"Consensus statement regarding the efficacy and safety of long-term low-dose colchicine in gout and cardiovascular disease","volume":"135","author":"Robinson","year":"2022","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejphar.2026.178725_bib52","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMoa2404147","article-title":"Zodasiran, an RNAi therapeutic targeting ANGPTL3, for mixed hyperlipidemia","volume":"391","author":"Rosenson Robert","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2026.178725_bib53","doi-asserted-by":"crossref","first-page":"H958","DOI":"10.1152\/ajpheart.00723.2018","article-title":"The renin-angiotensin system: going beyond the classical paradigms","volume":"316","author":"Santos","year":"2019","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2026.178725_bib54","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202201469R","article-title":"Colchicine exerts anti-atherosclerotic and -plaque-stabilizing effects targeting foam cell formation","volume":"37","author":"Schwarz","year":"2023","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2026.178725_bib55","article-title":"Therapeutic intervention with anti-complement component 5 antibody does not reduce NASH but does attenuate atherosclerosis and MIF concentrations in Ldlr-\/-.Leiden mice","volume":"23","author":"Seidel","year":"2022","journal-title":"Int. J. Mol. Sci. [Online]"},{"key":"10.1016\/j.ejphar.2026.178725_bib56","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.gene.2013.04.036","article-title":"Hepatic nuclear factor 4\u03b1 positively regulates complement C3 expression and does not interfere with TNF\u03b1-mediated stimulation of C3 expression in HepG2 cells","volume":"524","author":"Shavva","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.ejphar.2026.178725_bib57","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1084\/jem.147.4.1213","article-title":"Effect of colchicine on the antibody response. I. Enhancement of antibody formation in mice","volume":"147","author":"Shek","year":"1978","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2026.178725_bib58","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1084\/jem.147.4.1228","article-title":"Effect of colchicine on the antibody response. II. Demonstration of the inactivation of suppressor cell activities by colchicine","volume":"147","author":"Shek","year":"1978","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2026.178725_bib59","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.molimm.2013.06.001","article-title":"Complement factor H related proteins (CFHRs)","volume":"56","author":"Skerka","year":"2013","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ejphar.2026.178725_bib60","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.amjmed.2014.12.010","article-title":"Colchicine: old and new","volume":"128","author":"Slobodnick","year":"2015","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejphar.2026.178725_bib61","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2026.178725_bib62","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0021-9150(85)90164-9","article-title":"Immunoglobulins and complement components in human aortic atherosclerotic intima","volume":"55","author":"Vlaicu","year":"1985","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejphar.2026.178725_bib63","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s42255-021-00366-y","article-title":"Colchicine acts selectively in the liver to induce hepatokines that inhibit myeloid cell activation","volume":"3","author":"Weng","year":"2021","journal-title":"Nat. Metab."},{"key":"10.1016\/j.ejphar.2026.178725_bib64","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1161\/CIRCULATIONAHA.107.693382","article-title":"Apolipoprotein C-I is crucially involved in lipopolysaccharide-induced atherosclerosis development in apolipoprotein E-knockout mice","volume":"116","author":"Westerterp","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2026.178725_bib65","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1161\/HYPERTENSIONAHA.111.189456","article-title":"Acute reversal of endothelial dysfunction in the elderly after antioxidant consumption","volume":"59","author":"Wray","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2026.178725_bib66","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/ATVBAHA.117.310473","article-title":"APOC3 loss-of-function mutations, remnant cholesterol, low-density lipoprotein cholesterol, and cardiovascular risk: mediation- and meta-analyses of 137 895 individuals","volume":"38","author":"Wulff","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2026.178725_bib67","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.atherosclerosis.2021.08.039","article-title":"Apolipoprotein M and its impact on endothelial dysfunction and inflammation in the cardiovascular system","volume":"334","author":"Yao Mattisson","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejphar.2026.178725_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11020230","article-title":"Effects of colchicine in a rat model of diet-induced hyperlipidemia","volume":"11","author":"Z\u0103lar","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejphar.2026.178725_bib69","article-title":"Combination of colchicine and ticagrelor inhibits carrageenan-induced thrombi in mice","volume":"2022","author":"Zhang","year":"2022","journal-title":"Oxid. Med. Cell. Longev."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926002074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926002074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:53:44Z","timestamp":1778648024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926002074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":68,"alternative-id":["S0014299926002074"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178725","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Colchicine acutely reduces liver-secreted inflammatory and metabolic proteins in blood","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178725","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"178725"}}